Supernus Pharma Insider Sells $5.4 Million as Stock Surges 53% in a Year

A Supernus Pharmaceuticals executive reported the sale of 107,250 Common Stock shares over three days for a total value of about $5.4 million. Bhatt reported holding 17,044 shares of directly owned common stock after the transactions.